A new study suggests that genetically predicted rheumatoid arthritis (RA) may increase the risk of developing prostate cancer (PCa). The findings, published in Medicine on January 10, highlight the need for increased awareness and screening for prostate cancer in men with RA.
Examining the Connection Between Autoimmune Diseases and Cancer
Researchers from Mindong Hospital Affiliated with Fujian Medical University in China explored whether three common autoimmune diseases—rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and ankylosing spondylitis (AS)—were linked to an increased risk of prostate cancer.
To investigate this, they used a method called Mendelian randomization (MR), which analyzes genetic data from large genome-wide association studies (GWAS) to determine causal relationships between diseases. They also considered risk factors such as smoking and obesity to see if these could explain any observed associations.
Findings: RA Increases Prostate Cancer Risk
The results showed that genetically predicted RA was significantly linked to a higher risk of prostate cancer. Specifically, in a univariable MR analysis, RA was associated with a slightly increased risk of developing prostate cancer, with an odds ratio of 1.036.
This means that for individuals with a genetic predisposition to RA, the likelihood of developing prostate cancer is slightly higher compared to those without RA.
In contrast, no significant associations were found between systemic lupus erythematosus (SLE) or ankylosing spondylitis (AS) and prostate cancer. Additionally, a reverse MR analysis found no evidence that prostate cancer itself increases the risk of developing these autoimmune diseases.
Even after adjusting for smoking and obesity—two known risk factors for prostate cancer—the link between RA and prostate cancer remained significant. This suggests that RA itself, rather than lifestyle factors, plays a role in increasing prostate cancer risk.
Clinical Implications
The study’s authors emphasize that these findings should encourage healthcare providers to be more vigilant about prostate cancer screening in patients with RA. Since RA is a chronic inflammatory condition that affects the immune system, it may contribute to cancer risk through prolonged inflammation and immune dysfunction.
“The positive association between genetically predicted RA and prostate cancer risk found in our study highlights the importance of monitoring PCa risk in patients with RA,” the researchers wrote. “Clinicians should be aware of this potential comorbidity and consider including prostate cancer screening in routine checkups for RA patients.”
Next Steps in Research
While this study provides strong evidence of a genetic link between RA and prostate cancer, further research is needed to understand the biological mechanisms behind this association. Future studies should also investigate whether treating RA effectively could lower the risk of developing prostate cancer.
For now, these findings suggest that men with RA may benefit from more frequent prostate cancer screening, allowing for earlier detection and better outcomes.
If you care about cancer, please see recent studies about new way to increase the longevity of cancer survivors, and results showing new way to supercharge cancer-fighting T cells.
For more information about health, please see recent studies about how drinking milk affects risks of heart disease and cancer and results showing that vitamin D supplements could strongly reduce cancer death.
The research findings can be found in Medicine.
Copyright © 2025 Knowridge Science Report. All rights reserved.
